0001209191-18-002065.txt : 20180104 0001209191-18-002065.hdr.sgml : 20180104 20180104171405 ACCESSION NUMBER: 0001209191-18-002065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180104 DATE AS OF CHANGE: 20180104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAAB MICHAEL CENTRAL INDEX KEY: 0001321402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 18511015 MAIL ADDRESS: STREET 1: 1119 ST PAUL STREET CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-02 0 0001178879 AMICUS THERAPEUTICS INC FOLD 0001321402 RAAB MICHAEL C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 1 0 0 0 Common Stock 2018-01-02 4 M 0 9366 15.00 A 15180 D Common Stock 2018-01-02 4 S 0 9366 15.00 D 5814 D Stock Options (right to buy) 2.81 2018-01-02 4 M 0 5000 0.00 D 2011-06-15 2020-06-15 Common Stock 5000 5000 D Stock Options (right to buy) 7.51 2018-01-02 4 M 0 4366 0.00 D 2012-05-24 2021-05-24 Common Stock 4366 5634 D The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017. This price of $15.00 is the sole purchase price for the transactions reported on this line. This price of $15.00 is the sole sale price for the transactions reported on this line. /s/ Michael G. Raab 2018-01-04